MedTrace Logo

Investigating the Cognitive and Brain Health Benefits of Lean Pork Consumption

NCT07031076 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2025-12-26

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if eating more lean pork will lead to better cognition and a healthier brain in older adults. The main questions it aims to answer are:

* Does eating more lean pork lead to higher scores on cognitive tests and better quality of life?
* Does eating more lean pork lead to slower brain aging and/or better brain function?

Researchers will compare participants in the experimental group (participants undergoing the dietary intervention) to control participants (participants that do not undergo the intervention).

Participants will:

* Be instructed to prepare and consume ready-to-eat pork meals along with their regular diet and not eat any more pork other than what they are given; or be instructed to consume their regular diet
* Visit the study facilities once every week to pick up ready-to-eat pork meals and complete dietary surveys; or complete dietary surveys every 4 weeks
* Visit the study facilities before and after the 16-week of intervention period for researchers to study them

Conditions

  • Dietary Intervention
  • Dietary Proteins
  • Dietary Assessment
  • Older Adults (65 Years and Older)
  • Cognitive Ability, General

Interventions

DIETARY_SUPPLEMENT

Ready-to-eat lean pork in frozen, 5-oz packages

The dietary intervention lasts 16 weeks for each individual. Participants in the experimental group will receive this intervention. Each participant will acquire 4 portions of ready-to eat lean pork in frozen packages per week; each portion of ready-to-eat lean pork in this intervention will weigh 5 ounces.

Sponsors & Collaborators

  • National Pork Board

    collaborator OTHER

  • University of Nebraska Lincoln

    lead OTHER

Principal Investigators

  • Aron Barbey, PhD · University of Nebraska Lincoln

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07031076 on ClinicalTrials.gov